GlaxoSmithKline plc (GSK)

NYSE - NYSE Real Time Price. Currency in USD
40.38+0.06 (+0.15%)
As of 12:51 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close40.32
Bid40.37 x 3400
Ask40.38 x 600
Day's Range39.56 - 40.48
52wk Range37.82 - 45.58
1y Target EstN/A
Market Cap101.14B
P/E Ratio (ttm)2,523.75
Avg Vol (3m)2,756,472
Dividend & Yield1.87 (4.59%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    Drugmaker GSK returns to growth in China after torrid time

    GlaxoSmithKline comments on China during third-quarter results: * CEO Andrew Witty tells analysts GSK is fundamentally back to growth in China * China business up 24% in third quarter * Reflects particularly ...

  • Reuters3 hours ago

    British imports of cheap medicines dry up as pound falls

    The supply of cut-price branded prescription drugs into Britain is drying up as a sharp fall in sterling erodes profit margins for wholesalers engaged in the so-called parallel trade. Drugs, like other goods, can be freely traded across Europe's single market and Britain, along with Germany, has long been a profitable destination market for parallel traders who buy supplies in countries where prices are lower, like Greece. "What we are seeing is a deceleration of parallel trade," Andrew Witty, chief executive of GlaxoSmithKline, told reporters in a post-results call.

  • GlaxoSmithKline PLC (ADR) (GSK) Teams Up With Fimbrion Therapeutics, Inc.
    Insider Monkey3 hours ago

    GlaxoSmithKline PLC (ADR) (GSK) Teams Up With Fimbrion Therapeutics, Inc.

    GlaxoSmithKline plc (ADR) (NYSE:GSK) (GSK) has recently entered into a collaborative agreement with Fimbrion Therapeutics, Inc. to develop a small molecule drug for the prevention and treatment of urinary tract infections (UTIs). Collaboration Under the partnership, the two companies will mainly work on a joint project between GSK Discovery Partnerships with Academia (DPAc) and Fimbrion Therapeutics. […]